Joe Gagnon, CEO, 1upHealth, reviews how fast health care interoperability resources (FHIR) can aid organizations in improving #data collection, #care quality, and the consumer experience.

In the second part of this roundtable, Edmund Pezalla, MD, MPH; Adam Kittai, MD; Farrukh Awan, MD; and Jeffrey Dunn, PharmD, MBA, discuss cost and access challenges for treating #patients with zanubrutinib.

Want to stay up-to-date on all the featured content from our trusted brands? Follow their respective pages, designed to curate the latest clinical insights, industry news, podcasts with thought leaders in #PopulationHealth and more! @FirstReportMC @AnnalsofLTC @PharmaLearnNet

Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, describes several recent advancements in specific subsets of colorectal cancer and emphasizes the role of biomarker testing.

“With a full view of all aspects impacting members’ #health, providers and payers can proactively address issues to reduce adverse and costly events and ensure members have the chance to lead better lives,” writes Kim Glenn.

Speakers at the 22nd Population Health Colloquium shared how laboratory services might be utilized better to reduce costs and improve care quality across large populations.

Sign up for our newsletter and never miss out on the latest news, insights, and interviews about population #health management and more!

RT @PharmaLearnNet: Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending #trends that…

Saleem Alinur and Sharon Lee, vice presidents of managed care at Kindred Hospitals, share strategies for improving outcomes for medically complex patients, emphasizing how care coordination meetings at the LTACH level can benefit both payers and patients.

Scott Galbari, chief operating officer, Lyniate, shares challenges payers and providers have faced while trying to meet interoperability requirements and offers advice for organizations hoping to adopt new #technologies to ease the process.

Edmund Pezalla, MD, MPH; Adam Kittai, MD; Farrukh Awan, MD; and Jeffrey Dunn, PharmD, MBA, discuss how second generation BTK inhibitors are changing the #treatment paradigm and payer considerations in chronic lymphocytic leukemia.

Dr Kaminski revisits his past Population Points column “Confronting Vaccine Hesitancy,” compares the reality of then and now, and shares what he has learned along the way.

Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in #monkeypox cases in the US and reviews the efficacy of two #vaccines.

RT @FirstReportMC: Shawn Kwatra, MD, FAAD, Director, Johns Hopkins Itch Center, identifies unmet need for patients with atopic dermatitis a…

Want to stay up-to-date on all the featured content from our trusted brands? Follow their respective pages, designed to curate the latest clinical insights, industry news, podcasts with thought leaders in #PopulationHealth and more! @FirstReportMC @AnnalsofLTC @PharmaLearnNet

More than a half-million cups of an over-the-counter antihistamine are being recalled due to inadequately controlled #manufacturing processes.

Ed Pezalla, MD, MPH, chief executive officer of Enlightenment Bioconsult, LLC, provides insight on #challenges payers face when covering patients with spinal muscular atrophy, including proper diagnosis.

Enam Noor, CEO and founder, Insightin Health, shares advice for health plans to raise #CAHPS scores and overall Star Ratings by consolidating data, reorganizing workflows, and improving member experience.

RT @FirstReportMC: @pashtoonkasi MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, discusses…

In this commentary, Yvette C Terrie walks through the history of mail-order #pharmacy services and asks #healthcare practitioners and the #patients they serve to share their opinions.